Inventor · disambiguated record
Xiuwen Zhu
Also filed as: ZHU XIUWEN
23 granted patents·22 pending applications·157 citations·filing 2005–2025
95Inventor score
Files withARENA PHARM INC23KUMQUAT BIOSCIENCES INC8JONES ROBERT M5KYORIN SEIYAKU KK3SATTERTHWAIT ARNOLD2
Top patents by PatentIndex Score
45 records- 0196US11771695B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Granted Oct 3, 2023·4 cites·11 claims
- 0295US12286427B2Heterocyclic compounds and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2024·Granted Apr 29, 2025·3 cites·20 claims
- 0394US8778950B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2010·Granted Jul 15, 2014·21 cites·6 claims
- 0494US8580841B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Nov 12, 2013·21 cites·51 claims
- 0594US8415484B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersJONES ROBERT M·Filed 2009·Granted Apr 9, 2013·29 cites·48 claims
- 0693US9126932B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Sep 8, 2015·17 cites·61 claims
- 0792US11214548B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Granted Jan 4, 2022·3 cites·8 claims
- 0892US10632134B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Granted Apr 28, 2020·5 cites·16 claims
- 0992US9522133B2Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Granted Dec 20, 2016·9 cites·42 claims
- 1091US12209102B2Heterocyclic compounds and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2024·Granted Jan 28, 2025·1 cites·25 claims
- 1191US9867822B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2016·Granted Jan 16, 2018·7 cites·18 claims
- 1291US9492447B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2015·Granted Nov 15, 2016·9 cites·20 claims
- 1389US10392390B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2016·Granted Aug 27, 2019·6 cites·16 claims
- 1489US2025074874A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2024·Application pending·0 cites
- 1588US9597340B2Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Granted Mar 21, 2017·9 cites·17 claims
- 1685US9108969B2Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2013·Granted Aug 18, 2015·6 cites·33 claims
- 1781US10836764B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2017·Granted Nov 17, 2020·2 cites·39 claims
- 1881US9944606B2Cannabinoid receptor modulatorsJONES ROBERT M·Filed 2012·Granted Apr 17, 2018·3 cites·30 claims
- 1981US2023257349A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2022·Application pending·0 cites
- 2078US7745574B2Compounds that regulate apoptosisBURNHAM INST·Filed 2006·Granted Jun 29, 2010·2 cites·13 claims
- 2177US2022306586A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2021·Application pending·0 cites
- 2274US12365676B2Heterocyclic compounds and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2023·Granted Jul 22, 2025·0 cites·31 claims
- 2374US11746091B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Sep 5, 2023·0 cites·12 claims
- 2474US2024425525A1Heterocyclic compounds and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2572US2020407316A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2020·Application pending·0 cites
- 2667US2019135752A1SUBSTITUTED (1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2018·Application pending·0 cites
- 2767US2020069681A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2019·Application pending·0 cites
- 2865US2024398828A1Hetero-atom containing compounds and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2024·Application pending·0 cites
- 2964US12109219B2Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2020·Granted Oct 8, 2024·0 cites·20 claims
- 3064US2024254129A1Heterocyclic compounds and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3164US2018354907A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2018·Application pending·0 cites
- 3264US2024270736A1Macrocyclic heterocycles and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3363US2024166641A1Heterocycles and uses thereofKUMQUAT BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3463US2018280386A1Cannabinoid receptor modulatorsARENA PHARM INC·Filed 2017·Application pending·0 cites
- 3563US2025326773A1Mrgprx2 antagonists, pharmaceutical composition including mrgprx2 antagonist, and method of treating mrgprx2-mediated disease or disorderKYORIN SEIYAKU KK·Filed 2025·Application pending·0 cites
- 3662US11608339B25-HT2C receptor agonists and compositions and methods of useARENA PHARM INC·Filed 2020·Granted Mar 21, 2023·0 cites·20 claims
- 3762US2017217885A1SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERSARENA PHARM INC·Filed 2016·Application pending·0 cites
- 3859US2025326772A1Mrgprx2 antagonists, pharmaceutical composition including mrgprx2 antagonist, and method of treating mrgprx2-mediated disease or disorderKYORIN SEIYAKU KK·Filed 2025·Application pending·0 cites
- 3955US2014206649A1Cannabinoid receptor modulatorsTHATTE JAYANT·Filed 2012·Application pending·0 cites
- 4050US2013157260A1Identification of compounds that regulate apoptosisSATTERTHWAIT ARNOLD·Filed 2010·Application pending·0 cites
- 4148US2010292145A1Methods of regulating apoptosisSANFORD BURNHAM MEDICAL RES IN·Filed 2010·Application pending·0 cites
- 4248US2014066369A1Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related TheretoJONES ROBERT M·Filed 2012·Application pending·0 cites
- 4348US2015336966A1Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disordersARENA PHARM INC·Filed 2015·Application pending·0 cites
- 4442US12304897B215-PGDH inhibitorsKYORIN SEIYAKU KK·Filed 2020·Granted May 20, 2025·0 cites·24 claims
- 4539US2006198832A1Peptide drugs for chronic lymphocytic leukemia (CLL) and other cancersSATTERTHWAIT ARNOLD·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →